Significant medical pathology discovered during a male infertility evaluation

被引:68
作者
Kolettis, PN [1 ]
Sabanegh, ES
机构
[1] Univ Alabama, Div Urol, Birmingham, AL 35294 USA
[2] Wilford Hall USAF Med Ctr, San Antonio, TX 78236 USA
关键词
infertility; male; evaluation studies; pathology;
D O I
10.1016/S0022-5347(05)66104-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Because a pregnancy can be achieved without a male infertility evaluation, some have questioned its usefulness. However, by bypassing a urological evaluation the man might not learn the cause of infertility and not be offered specific corrective therapy. In addition, men with subfertility may have a serious underlying medical or genetic problem that could also be overlooked. We determine the incidence of significant medical pathology discovered during a male infertility evaluation at 2 academic infertility practices. Materials and Methods: All men examined for either primary or secondary infertility were included in our study, while men seen for vasectomy reversal were not. All patients underwent evaluation, consisting of a complete history, physical examination, semen analysis, hormone testing, urinalysis and genetic testing when appropriate. Results: Significant medical pathology was discovered in 33 of 536 (6%) patients. A total of 27 patients had genetic abnormalities,: including cystic fibrosis mutations in 24 and karyotypic abnormalities in 3. Of the remaining 6 patients 1 had testis cancer, 1 prostate cancer, 3 diabetes mellitus and 1 hypothyroidism. Conclusions: Significant medical pathology can be detected by a male infertility evaluation. In addition to identifying the cause of infertility, the evaluation may uncover conditions that threaten the health of the male partner or any potential offspring.
引用
收藏
页码:178 / 180
页数:3
相关论文
共 19 条
[1]   CONGENITAL BILATERAL ABSENCE OF THE VAS-DEFERENS - A PRIMARILY GENITAL FORM OF CYSTIC-FIBROSIS [J].
ANGUIANO, A ;
OATES, RD ;
AMOS, JA ;
DEAN, M ;
GERRARD, B ;
STEWART, C ;
MAHER, TA ;
WHITE, MB ;
MILUNSKY, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (13) :1794-1797
[2]  
[Anonymous], 1997, INFERTILITY MALE
[3]   Prospective follow-up study of 877 children born after intracytoplasmic sperm injection (ICSI), with ejaculated epididymal and testicular spermatozoa and after replacement of cryopreserved embryos obtained after ICSI [J].
Bonduelle, M ;
Wilikens, A ;
Buysse, A ;
VanAssche, E ;
Wisanto, A ;
Devroey, P ;
VanSteirteghem, AC ;
Liebaers, I .
HUMAN REPRODUCTION, 1996, 11 :131-155
[4]   TREATING MALE-INFERTILITY NEEDS MORE CLINICAL ANDROLOGY, NOT LESS [J].
CUMMINS, JM ;
JEQUIER, AM .
HUMAN REPRODUCTION, 1994, 9 (07) :1214-1219
[5]   INTRACYTOPLASMIC SPERM INJECTION - WHAT KIND OF REPRODUCTION IS BEING ASSISTED [J].
DEJONGE, CJ ;
PIERCE, J .
HUMAN REPRODUCTION, 1995, 10 (10) :2518-2520
[6]   Do we treat the male or his gamete? [J].
Devroey, P ;
Vandervorst, M ;
Nagy, P ;
Van Steirteghem, A .
HUMAN REPRODUCTION, 1998, 13 :178-185
[7]  
DUNPHY BC, 1989, FERTIL STERIL, V52, P454
[8]  
HONIG SC, 1994, FERTIL STERIL, V62, P1028
[9]  
JAFFE T, 1997, INFERTILITY MALE, P280
[10]  
LIPSHULTZ LL, 1995, CONT UROL SEP, P33